Marist College’s Board of Trustees added five individuals to its board and elected a new chair at its annual meeting on Nov. 15. Genine McCormick, a CPA who has previously worked for Arthur Andersen & Co and Morgan Stanley, has served nearly 15 years on the board, most recently as vice chair and chair of the Audit Committee, and was unanimously elected to her first three-year term as chair. Ross Mauri, who concluded his second term as chair, will continue on the Board as the Immediate Past Chair. In addition to her distinguished record of Board service, McCormick has been [...]Caitlin Clark raised the profile of women’s basketball to unprecedented levels in both the college ranks and the WNBA, and Tuesday she was named the AP Female Athlete of the Year for her impact on and off the court. After leading Iowa to the national championship game, Clark was the top pick in the WNBA draft as expected and went on to win rookie of the year honors in the league. Fans packed sold-out arenas and millions of television viewers tuned in to follow her journey. Clark’s exploits were far reaching, casting a light on other women’s sports leagues along the way. A group of 74 sports journalists from The Associated Press and its members voted on the award. Clark received 35 votes, Olympic gymnast Simone Biles was second with 25 and boxer Imane Khelif was third, getting four votes. Clark is only the fourth women’s basketball player to be honored as the female athlete of the year since it was first presented in 1931, joining Sheryl Swoopes (1993), Rebecca Lobo (1995) and Candace Parker (2008, 2021). “I grew up a fan of Candace Parker and the people who came before me and to be honored in this way, is super special and I’m thankful,” Clark said in a phone interview. “It was a great year for women’s basketball and women’s sports.” Shohei Ohtani won the AP Male Athlete of the Year on Monday for the third time. Clark broke the NCAA Division I career scoring record for both men and women finishing her career with 3,951 points while guiding Iowa to its second consecutive national championship game. After her Hawkeyes lost t South Carolina for the title, Gamecocks coach Dawn Staley took the mic during her team’s celebration and said, “I want to personally thank Caitlin Clark for lifting up our sport.” For all the success Clark has had and the attention she has brought to women’s basketball, she is often the centerpiece of debates and online toxicity towards her and other players in the league. For her part, Clark has disavowed the toxic discourse. Lobo also has been impressed with the way the 22-year-old Clark has handled the pressure and attention that has come her way. “I would say she’s navigated it almost flawlessly. she hasn’t had an big missteps or misspeaks at a time you’re under constant scrutiny,” Lobo said. “She’s seemed to say and do all the right things. That’s just incredible at a time when it’s constant attention and scrutiny. She has not done anything to tarnish this sort of mild persona she has.” As Clark handled the praise — and the backlash — during the heat of competition, it was hard for her to appreciate just what she was able accomplish over the past year. But after having time to reflect on the whirlwind tour, she appreciates those who were there alongside her for the ride. “I’m thankful for the people I got to do it with,” Clark said. “A year ago I was still in the early part of my senior year in college. ... How fast things change, and now I can see how great a college season it was.” Iowa sold out all of its games at home and on the road with Clark as the main attraction. That momentum continued into the pros. Her No. 22 jersey was prevalent wherever she played during her rookie season and will be retired at Iowa. “You’d be remiss not to acknowledge how crazy her fan base is and the eyes she gets with everything she does,” said Indiana Pacers guard Tyrese Haliburton, who was often spotted courtside at Clark’s Indiana Fever games. “It’s a different type of popularity, she’s one of the most popular athletes in the world. It’s not just women’s sports anymore. “It’s really cool to see and she just handles it with such grace.” Clark said she enjoys spending time with fans at games, usually taking a few minutes before and after games to sign autographs. “For me it’s still really fun,” she said. “Whether it’s 15 seconds or 10 seconds or 5 seconds can be very impactful in a young girl and young boys life. Seeing the fans going crazy an hour before tipoff, I never take that for granted. That’s super cool and I never want that to go away.” After a slow start to her WNBA career, Clark eventually found her stride there too. She set the single-game assist record with 19 and also had 337 assists on the season to break that mark as well. Clark, known for her logo-distance 3-pointers, was the fastest player to reach 100 3’s when she did it in 34 games which helped Indiana reach the playoffs for the first time since 2016. Lobo, who won the AP female athlete of the year award after lifting UConn to its first national championship, was on the court for launch of the WNBA two years later. The ESPN analyst sees Clark’s ascension as something different. “She’s brought unprecedented attention both in the building, but also viewership to the sport that was worthy of it but didn’t have it yet,” Lobo said. “There’s never been anything like this. “That timeframe from 1995-97 was a baby step in the progression of it all. This is a giant leap forward. I’ve never seen anything like this. There’s more attention then the sports ever had.” The numbers have been record breaking when Clark is part of a broadcast: — TV viewership in the WNBA was up 300% thanks in large part to Clark with ABC, CBS, ION, ESPN, and ESPN2 all having record viewers when Fever games were on. — The NCAA women’s championship game outdrew the men on TV for the first time in the sport’s 42-year history with 18.9 million viewers tuning it to watch the event. It was the second most watched women’s sporting event outside of the Olympics in the history of U.S. television. — The 2024 WNBA draft was the most-watched in league history with 2.4 million viewers. Clark credits the community of women athletes for the popularity increase of women’s sports, saying “we” did this or “we” did that when asked about it. “It’s fascinating, you don’t always appreciate how many people 18 million is,” Clark said. “You see that number against a college football game or the Masters or whatever it is as far as the biggest sporting events in our country and it puts it in perspective. We outdrew the men’s Final Four.”TORONTO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Blockmate Ventures Inc. (TSX.V: MATE) (OTCQB: MATEF) (FSE: 8MH1) (" Blockmate ” or the " Company ”) is pleased to announce that it has closed its strategic investment (the " Offering ”) involving a group of strategic investors led by Antanas Guoga (Tony G) for gross proceeds of $1,400,000. This strategic funding supports Blockmate's pursuit of industry leadership in blockchain innovation and underscores our commitment to sustainable and transformative technology. In connection with completion of the Offering, the Company has issued 14,000,000 units (each, a " Unit ”) at a price of $0.10 per Unit. Each Unit consists of one common share, and one common share purchase warrant exercisable to acquire a further common share at a price of $0.50 until December 23, 2027. All securities issued in connection with the Offering are subject to statutory restrictions on resale until April 24, 2025, in accordance with applicable securities laws. In addition, Tony G has voluntarily agreed to restrict resale of the 10,000,000 Units he acquired in the Offering until December 23, 2025. No finders' fees or commissions were paid by the Company in connection with completion of the Offering. Incentive Grant The Company also announces that it has granted 5,275,000 incentive stock options (the " Options ”), 1,200,000 restricted share units (the " RSUs ”) and 5,000,000 deferred share units (the " DSUs ”) in accordance with its omnibus incentive plan (the " Incentive Plan ”) adopted by shareholders at the annual general and special meeting held on November 23, 2023. 625,000 of the Options vest immediately and are exercisable at a price of $0.21 for a period of thirty-six months. The remaining 5,000,000 Options vest quarterly over a twenty-four month period, and are exercisable at a price of $0.21 for a period of forty-eight months. The RSUs vest and will be settled in common shares of the Company after twelve months. The DSUs vest after twelve months but will only be settled in common shares of the Company upon the departure of the holder from the Company. 2,725,000 of the Options and all of the DSUs exceed the available room under the Incentive Plan. The Company intends to seek approval of shareholders to increase the size of the Incentive Plan at the next annual general meeting and will at that time seek ratification from shareholders for the additional Options and the DSUs. Until such time as shareholder ratification has been received, the additional Options and DSUs will not vest and will not be eligible for exercise or settlement. In the event shareholders elect not to ratify the grant, and room within the Incentive Plan is not available at the time, the additional Options and DSUs will be cancelled. Early Warning Disclosure In connection with the incentive grant, Domenic Carosa, a director of the Company, has been issued 5,000,000 Options and 5,000,000 DSUs. Prior to the grant, Mr. Carosa controlled 17,252,400 common shares, 1,500,000 incentive stock options, and 3,000,000 common share purchase warrants, of the Company, all of which are held by Carosa Corporation B.V., a holding company controlled by Domenic Carosa. The common shares controlled by Mr. Carosa prior to the grant represent approximately 15.1% of the issued and outstanding common shares of the Company. Following the grant, Mr. Carosa has control and direction over 17,252,400 common shares, 6,500,000 Options, 3,000,000 common share purchase warrants and 5,000,000 DSUs of the Company. Assuming the exercise and conversion of all of the Options, share purchase warrants and DSUs controlled by Mr. Carosa, he would have control and direction over 31,752,400 common shares of the Company representing approximately 19.8% of the then outstanding common shares of the Company. Mr. Carosa has acquired the securities for investment purposes and in connection with his compensation as a director of the Company and, as disclosed in the accompanying Early Warning Report, may in the future acquire or dispose of securities of the Company, through the market, privately or otherwise, as circumstances or market conditions warrant. A copy of the Early Warning Report filed with the applicable securities regulators regarding the above acquisition will be available under the profile for the Company on SEDAR+ ( www.sedarplus.ca ). About Blockmate Ventures Inc. Blockmate is a venture creator focussing on building fast-growing technology businesses relating to cutting edge sectors such as blockchain and renewable energy. Working with prospective founders, projects in incubation can benefit from the Blockmate ecosystem that offers tech, services, integrations and advice to accelerate the incubation of projects towards monetization. Recent projects include Hivello (download our free passive income app at www.hivello.com ) and Sunified, digitising solar energy. The leadership team at Blockmate have successfully founded successful tech companies from the Dotcom era through to the social media era. Learn more about being a Blockmate at: www.blockmate.com/ . Blockmate welcomes investors to join the Company's mailing list for the latest updates and industry research by subscribing at https://www.blockmate.com/subscribe . ON BEHALF OF THE BOARD OF DIRECTORS Justin Rosenberg, Chief Executive Officer Blockmate Ventures Inc. [email protected] (+1-580-262-6130) Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release Forward-Looking Information This news release contains "forward-looking statements” or "forward-looking information” (collectively, "forward-looking statements”) within the meaning of applicable securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on the assumptions, expectations, estimates and projections as of the date of this news release. Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors that could cause actual events or results to differ from those expressed or implied by forward-looking statements contained herein. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Raindrop disclaims any obligation to update any forward-looking statements, whether because of new information, future events or otherwise, except as may be required by applicable securities laws. Readers should not place undue reliance on forward-looking statements.
David Coote will not appeal against the termination of his contract by referees’ body PGMOL, the PA news agency understands. Coote was sacked earlier this month after the emergence of a video in which he made derogatory remarks about Liverpool and their former manager Jurgen Klopp. Professional Game Match Officials Limited (PGMOL) said that a thorough investigation had concluded he was “in serious breach of the provisions of his employment contract, with his position deemed untenable”. “Supporting David Coote continues to be important to us and we remain committed to his welfare,” PGMOL’s statement on December 9 added. Coote had the right to appeal against the decision but PA understands the Nottinghamshire referee has decided not to. The video which triggered PGMOL’s investigation into Coote’s conduct first came to public attention on November 11. In it, Coote is asked for his views on a Liverpool match where he has just been fourth official, and describes them as “s***”. He then describes Klopp as a “c***”, and, asked why he felt that way, Coote says the German had “a right pop at me when I reffed them against Burnley in lockdown” and had accused him of lying. “I have got no interest in speaking to someone who’s f****** arrogant, so I do my best not to speak to him,” Coote said. Later in the video, Coote again refers to Klopp, this time as a “German c***”. The Football Association opened its own investigation into that video, understood to be centred on that last comment and whether Coote’s reference to Klopp’s nationality constituted an aggravated breach of its misconduct rules. The investigation by PGMOL which led to Coote’s contract being terminated is also understood to have looked at another video which appeared to show Coote snorting a white powder, purportedly during Euro 2024 where he was one of the assistant VARs for the tournament. European football’s governing body UEFA also appointed an ethics investigator to look into the matter.Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle Griffin had no trouble getting them. The 38-year-old information technology worker from New Mexico had a prescription. Her pharmacy had the drugs in stock. And her health insurance covered all but $25 to $50 of the monthly cost. For Griffin, the hardest part of using the new drugs wasn’t access. It was finding out that the much-hyped medications didn’t really work for her. “I have been on Wegovy for a year and a half and have only lost 13 pounds,” said Griffin, who watches her diet, drinks plenty of water and exercises regularly. “I’ve done everything right with no success. It’s discouraging.” In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body weight — up to 50 pounds or more in many cases. But roughly 10% to 15% of patients in those trials were “nonresponders” who lost less than 5% of their body weight. Now that millions of people have used the drugs, several obesity experts told The Associated Press that perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications. It's a little-known consequence of the obesity drug boom, according to doctors who caution eager patients not to expect one-size-fits-all results. “It's all about explaining that different people have different responses,” said Dr. Fatima Cody Stanford, an obesity expert at Massachusetts General Hospital The drugs are known as GLP-1 receptor agonists because they mimic a hormone in the body known as glucagon-like peptide 1. Genetics, hormones and variability in how the brain regulates energy can all influence weight — and a person's response to the drugs, Stanford said. Medical conditions such as sleep apnea can prevent weight loss, as can certain common medications, such as antidepressants, steroids and contraceptives. “This is a disease that stems from the brain,” said Stanford. “The dysfunction may not be the same” from patient to patient. Despite such cautions, patients are often upset when they start getting the weekly injections but the numbers on the scale barely budge. “It can be devastating,” said Dr. Katherine Saunders, an obesity expert at Weill Cornell Medicine and co-founder of the obesity treatment company FlyteHealth. “With such high expectations, there’s so much room for disappointment.” That was the case for Griffin, who has battled obesity since childhood and hoped to shed 70 pounds using Wegovy. The drug helped reduce her appetite and lowered her risk of diabetes, but she saw little change in weight. “It’s an emotional roller coaster,” she said. “You want it to work like it does for everybody else.” The medications are typically prescribed along with eating behavior and lifestyle changes. It’s usually clear within weeks whether someone will respond to the drugs, said Dr. Jody Dushay, an endocrine specialist at Beth Israel Deaconess Medical Center. Weight loss typically begins right away and continues as the dosage increases. For some patients, that just doesn't happen. For others, side effects such as nausea, vomiting and diarrhea force them to halt the medications, Dushay said. In such situations, patients who were counting on the new drugs to pare pounds may think they’re out of options. “I tell them: It's not game over,” Dushay said. Trying a different version of the new class of drugs may help. Griffin, who didn't respond well to Wegovy, has started using Zepbound, which targets an additional hormone pathway in the body. After three months of using the drug, she has lost 7 pounds. “I'm hoping it's slow and steady,” she said. Other people respond well to older drugs, the experts said. Changing diet, exercise, sleep and stress habits can also have profound effects. Figuring out what works typically requires a doctor trained to treat obesity, Saunders noted. “Obesity is such a complex disease that really needs to be treated very comprehensively,” she said. “If what we’re prescribing doesn’t work, we always have a backup plan.” The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.Kansas once required voters to prove citizenship. That didn't work out so well
Russian state news agencies say ousted Syrian leader Bashar Assad is in Moscow and given asylum DAMASCUS, Syria (AP) — Russian state news agencies say the ousted Syrian President Bashar Assad has arrived in Moscow with his family and been given asylum, hours after close ally Russia said he left Syria after negotiations with rebel groups. The Russian agencies, Tass and RIA, cited an unidentified Kremlin source. The Associated Press is not immediately able to verify the reports but has contacted the Kremlin for comment. Assad reportedly left Syria early Sunday, and Syrians have been pouring into streets echoing with celebratory gunfire after a stunning rebel advance reached the capital, ending the Assad family’s 50 years of iron rule. The fall of Bashar Assad after 13 years of war in Syria brings to an end a decades-long dynasty BEIRUT (AP) — Syrian President Bashar Assad has fled the country. Assad’s departure on Sunday brings to a dramatic close his nearly 14-year struggle to hold onto power in a brutal civil war that became a proxy battlefield for regional and international powers. Assad’s exit stood in stark contrast to his first months as Syria’s unlikely president in 2000, when many hoped he would be a young reformer after three decades of his father’s iron grip. But faced with protests of his rule that erupted in March 2011, Assad turned to his father's brutal tactics to crush dissent. A long stalemate was quickly broken when opposition groups in northwest Syria launched a surprise offensive late last month. Who is Abu Mohammed al-Golani, the leader of the insurgency that toppled Syria's Assad? BEIRUT (AP) — Abu Mohammed al-Golani, the militant leader who led the stunning insurgency that toppled Syria’s President Bashar Assad, has spent years working to remake his public image and that of his fighters. He renounced longtime ties to al-Qaida and depicts himself as a champion of pluralism and tolerance. The extent of that transformation from jihadi extremist to would-be state builder is now put to the test. The 42-year-old al-Golani is labeled a terrorist by the United States. He has not appeared publicly since Damascus fell early Sunday. But he and his insurgent force, Hayat Tahrir al-Sham, stand to be a major player in whatever comes next. Trump says he can't guarantee tariffs won't raise US prices and won't rule out revenge prosecutions WASHINGTON (AP) — Donald Trump says he can’t guarantee his promised tariffs on key U.S. foreign trade partners won’t raise prices for American consumers. And he's suggesting once more that some political rivals and federal officials who pursued legal cases against him should be imprisoned. The president-elect made the comments in a wide-ranging interview with NBC’s “Meet the Press” that aired Sunday. He also touched on monetary policy, immigration, abortion and health care, and U.S. involvement in Ukraine, Israel and elsewhere. Trump often mixed declarative statements with caveats, at one point cautioning “things do change.” Trump calls for immediate ceasefire in Ukraine and says a US withdrawal from NATO is possible WASHINGTON (AP) — Donald Trump is pushing Russian leader Vladimir Putin to act to reach an immediate ceasefire with Ukraine. Trump describes it as part of his active efforts as president-elect to end the war despite being weeks from taking office. Trump also said he would be open to reducing military aid to Ukraine and pulling the United States out of NATO. Those are two threats that have alarmed Ukraine, NATO allies and many in the U.S. national security community. Ukrainian President Volodymyr Zelenskyy says any deal would have to pave the way to a lasting peace. The Kremlin's spokesman says Moscow is open to talks with Ukraine. The hunt for UnitedHealthcare CEO's elusive killer yields new evidence, but few answers NEW YORK (AP) — Police don’t know who he is, where he is, or why he did it. As the frustrating search for UnitedHealthcare CEO Brian Thompson’s killer got underway for a fifth day Sunday, investigators reckoned with a tantalizing contradiction: They have troves of evidence, but the shooter remains an enigma. One conclusion they are confident of, however: It was a targeted attack, not a random one. On Sunday morning, police declined to comment on the contents of a backpack found in Central Park that they believe was carried by the killer. South Korean prosecutors detain ex-defense chief over martial law imposition SEOUL, South Korea (AP) — South Korean prosecutors have detained a former defense minister who allegedly recommended last week’s brief but stunning martial law imposition to President Yoon Suk Yeol. Local media say that ex-Defense Minister Kim Yong Hyun voluntarily appeared on Sunday at a Seoul prosecutors’ office, where he had his mobile phone confiscated and was detained. A law enforcement official says Kim was later sent to a Seoul detention facility. Kim's detention came a day after Yoon avoided an opposition-led bid to impeach him, with most ruling party lawmakers boycotting a floor vote to prevent a two-thirds majority needed to suspend his presidential powers. Trump's return may be a boon for Netanyahu, but challenges abound in a changed Middle East TEL AVIV, Israel (AP) — Israeli Prime Minister Benjamin Netanyahu is jubilant about President-elect Donald Trump's return to the White House. Trump's first term policies skewed heavily in favor of Israel, and he has picked stalwart Israel supporters for key positions in his administration. But much has transpired since Trump left office in early 2021. The turmoil in the Middle East, the lofty ambitions of Netanyahu’s far-right governing coalition and Netanyahu’s own personal relationship with the president-elect could dampen that enthusiasm and complicate what on the surface looks like a seamless alliance. A farming project in South Africa is helping deaf people build skills and find jobs JOHANNESBURG (AP) — In South Africa, where the general unemployment rate is over 32%, deaf people face even steeper hurdles. Unlike their counterparts who can hear and speak, they must struggle to communicate in sign language while trying to gain opportunities for jobs and skills development. Now a deaf entrepreneur who quit her job at one of the biggest banks in the country has created an organization where the deaf can be trained in agriculture, develop their skills and earn a sustainable living. The farming sector is emerging as a solace for those with disabilities who also face the dire levels of unemployment in Africa’s most developed economy. First 12-team College Football Playoff set, Oregon seeded No. 1 and SMU edges Alabama for last spot SMU captured the last open spot in the 12-team College Football Playoff, bumping Alabama to land in a bracket that placed undefeated Oregon at No. 1. The selection committee preferred the Mustangs (11-2), losers of a heartbreaker in the Atlantic Coast Conference title game, who had a far less difficult schedule than Alabama (9-3) of the SEC but one fewer loss. The first-of-its-kind 12-team bracket marks a new era for college football, though the Alabama-SMU debate made clear there is no perfect formula. The tournament starts Dec. 20-21 with four first-round games. It concludes Jan. 20 with the national title game in Atlanta.OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec 12, 2024-- Takeda will host an investor R&D Day today beginning at 8:30 a.m. JST in Tokyo. The meeting will focus on programs in the company’s late-stage pipeline, the transformative value they could deliver to patients, and the market opportunities they represent. “We are focused on advancing our innovative pipeline and accelerating late-stage programs to deliver sustainable revenue growth to 2030 and beyond, building upon the strong momentum of our Growth and Launch Products,” said Christophe Weber, Takeda chief executive officer. “The first three Phase 3 programs will read out in 2025, initiating a cadence of potential filings across multiple indications over the next several years.” The late-stage pipeline includes oveporexton (TAK-861), zasocitinib (TAK-279), rusfertide (TAK-121), mezagitamab (TAK-079), fazirsiran (TAK-999) and elritercept (TAK-226). Combined these programs have potential peak revenue 1 of $10B - $20B. Data from three Phase 3 programs is expected to read out in 2025: Filings for these three indications are expected in fiscal years 2025 and 2026. Five additional indication filings for late-stage programs are on pace for fiscal years 2027 through 2029: “Takeda has established an exciting, late-stage pipeline of transformative therapies that we believe will deliver value to our company and, most importantly, to the patients we serve around the world,” said Andy Plump, president of R&D at Takeda. “As we continue scaling our capabilities and maximizing R&D investment to deliver the late-stage pipeline, we are also progressing an exciting early-stage pipeline, supporting a cutting-edge research organization, and focusing on creative business development across our therapeutic areas to sustain Takeda’s future and continue to meet significant unmet patient needs.” The meeting includes the following presentations and speakers: Christophe Weber, President & CEO Andy Plump, President, Research and Development Sarah Sheikh, Head of Neuroscience Therapeutic Area Unit and Head of Global Development Ramona Sequeira, President of Global Portfolio Division Chinwe Ukomadu, Head of Gastrointestinal and Inflammation Therapeutic Area Unit Ramona Sequeira, President of Global Portfolio Division Teresa Bitetti, President Global Oncology Business Unit P.K. Morrow, Head of Oncology Therapeutic Area Unit A live webcast of the meeting begins at 8:30 a.m. JST December 13 (6:30 p.m. EST December 12). Presentations are available on the where a video replay will be available following the meeting. Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit . For the purposes of this notice, “press release” means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws. The companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, “Takeda” is sometimes used for convenience where references are made to Takeda and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies. This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could”, “anticipates”, “estimates”, “projects” or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States; competitive pressures and developments; changes to applicable laws and regulations, including global health care reforms; challenges inherent in new product development, including uncertainty of clinical success and decisions of regulatory authorities and the timing thereof; uncertainty of commercial success for new and existing products; manufacturing difficulties or delays; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other facets of its business; the timing and impact of post-merger integration efforts with acquired companies; the ability to divest assets that are not core to Takeda’s operations and the timing of any such divestment(s); and other factors identified in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: or at . Takeda does not undertake to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results. References in this press release to peak revenue potential ranges are estimates that have not been adjusted for probability of technical and regulatory success (PTRS) and should not be considered a forecast or target. These peak revenue potential ranges represent Takeda’s assessments of various possible future commercial scenarios that may or may not occur. References in this press release to PTRS are to internal estimates of Takeda regarding the likelihood of obtaining regulatory approval for a particular product in a particular indication. These estimates reflect the subjective judgment of responsible Takeda personnel and have been approved by Takeda’s Portfolio Review Committee for use in internal planning. This press release contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, in different dosages, or in different strengths. Nothing contained herein should be considered a solicitation, promotion or advertisement for any prescription drugs including the ones under development. Elritercept is included for reference only. Takeda entered into an exclusive license agreement with Keros for global rights, in all territories outside of mainland China, Hong Kong and Macau, to Elritercept. The closing of the transaction is subject to receipt of regulatory approval(s), expected in the first calendar quarter of 2025. Takeda does not currently have rights to Elritercept. ___________________________ 1 References in this presentation to peak revenue potential are estimates that have not been adjusted for probability of technical and regulatory success (PTRS) and should not be considered a forecast or target. These peak revenue ranges represent Takeda’s assessments of various possible future commercial scenarios that may or may not occur. View source version on : CONTACT: Investor Relations Christopher O’Reilly +81 (0) 90-6481-3412 Takeda Media Relations KEYWORD: MASSACHUSETTS UNITED STATES JAPAN NORTH AMERICA ASIA PACIFIC INDUSTRY KEYWORD: ONCOLOGY HEALTH NEUROLOGY CLINICAL TRIALS PHARMACEUTICAL BIOTECHNOLOGY SOURCE: Takeda Pharmaceutical Company Limited Copyright Business Wire 2024. PUB: 12/12/2024 05:30 PM/DISC: 12/12/2024 05:30 PMSAUNDERS: Santa Biden’s latest Christmas present is for murderers
Pearl Diver Credit Company Inc. Prices Offering of Series A Preferred StockThe report builds on Governor Kathy Hochul's efforts to advance New York's global reputation as the place where businesses come to grow, innovate, and create the future of emerging technologies. NEW YORK , Dec. 12, 2024 /PRNewswire/ -- (NYSE: IBM ) – The Emerging Technology Advisory Board (ETAB) today released its first report to elevate New York as an AI leader. The report provided recommendations to bolster the State's commitment to responsible development and implementation of AI. First introduced by Governor Kathy Hochul in June 2024 , the ETAB was established as an independent advisory board to chart the course for a thriving emerging technology ecosystem in New York State . The Advisory Board is co-chaired by IBM Chief Executive Officer Arvind Krishna and Girls Who Code Chief Executive Officer Dr. Tarika Barrett and is comprised of leaders from the private sector and nonprofit and foundation organizations. With input from over 40 external stakeholders and experts, the report details how New York is well-positioned to be at the forefront of AI advancement. This includes leveraging its robust economy, extensive tech talent pool, academic excellence, legacy for innovation, and groundbreaking investments in AI and AI-adjacent industries. In reviewing the state's current landscape, the Advisory Board also identified potential challenges, such as ensuring the workforce is equipped with the skills and resources necessary to succeed in the age of AI. The ETAB took a deeper look at how these challenges could impact New York organizations and communities – and, based on these insights, proposed three ambitions for the State of New York : Guided by these ambitions, the report sets forth nine recommendations – each backed by a thorough framework and next steps – designed to foster public-private partnerships and balance priorities of timely impact and sufficient scale necessary to help drive responsible AI adoption in New York . " New York State is furthering its legacy of innovation and invention for the rest of the world to follow, setting a standard of greatness – and we've only just begun," Governor Hochul said. "Since the beginning of my administration I have been laser-focused on bringing good paying jobs to this state, which is why we need ethical and responsible AI that improves the lives of all New Yorkers and delivers accessible, equitable and future proof jobs with it. I want to thank the members of the Emerging Technology Advisory Board, who took the time to form these recommendations. I look forward to reviewing the report and to working with experts and stakeholders from every sector as we forge an equitable and dynamic future for AI in New York ." "The Emerging Technology Advisory Board has delivered on its first goal to provide a blueprint that positions New York as a frontrunner in trustworthy AI," said Arvind Krishna . "This comprehensive set of recommendations will help drive an innovative AI ecosystem, ensure responsible AI deployment at scale, foster a resilient workforce, and empower all New Yorkers with equitable access to the benefits of AI." "The recommendations of the Emerging Technology Advisory Board reflect a collective effort to ensure that the advancement of artificial intelligence benefits industries and workers across New York ," said Tarika Barrett . "These comprehensive proposals aim not only to foster economic growth and innovation but also to uphold our commitment to a technological future that mirrors the diversity and values of our communities." As the Emerging Technology Advisory Board shares its recommendations with the State of New York , it underscores the joint effort, commitment and close collaboration it will take between the State's leadership, Advisory Board institutions, private sector, nonprofit organizations, philanthropic organizations, thought leaders and advocates to fortify New York as an innovation hub for future technologies. Read the full report here . About IBM IBM is a leading provider of global hybrid cloud and AI, and consulting expertise. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. More than 4,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM's hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM's breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and consulting deliver open and flexible options to our clients. All of this is backed by IBM's long-standing commitment to trust, transparency, responsibility, inclusivity and service. Visit www.ibm.com for more information. About Girls Who Code Girls Who Code is an international nonprofit organization working to close the gender gap in technology, and is leading the movement to inspire, educate, and equip students who identify as girls or nonbinary with the computing skills needed to pursue 21st century opportunities. Since launching in 2012, Girls Who Code has reached 670,000 students through our in-person and virtual programming, and 218,000 of our alumni are college or career-aged. Girls Who Code has sparked culture change through marketing campaigns and advocacy efforts, generating 14 Billion engagements globally. In 2019, the organization was named the #1 Most Innovative Non-Profit on Fast Company's Most Innovative Companies list, and in 2023 was named one of Fast Company's Brands That Matter. The organization was also named one of NonProfit Times' Best Nonprofits to Work For in 2022 and 2023. Media Contact Caitlin O'Neill , IBM Corporate Communications caitlin.oneill@ibm.com View original content to download multimedia: https://www.prnewswire.com/news-releases/new-york-emerging-technology-advisory-board-publishes-first-report-outlining-vision-to-elevate-leadership-in-ai-302330851.html SOURCE IBM
These are the four up-and-coming British companies I recommend investing in for real rewards next year and beyond, by shares guru JOANNE HART By JOANNE HART Updated: 16:55, 29 December 2024 e-mail 2 View comments Stock markets are intended to help companies grow. However, that theory has been sorely tested this year, with many firms hit by a cruel combination of economic uncertainty and investor apathy. Rachel Reeves's Budget made matters worse but this is no time for investors to turn their backs on Britain. Many UK stocks have huge potential. Often undervalued by the stock market, they have proved their resilience in recent years and shown they can move forward, even when conditions are tough. Midas top picks for 2025 include four such businesses, drawn from very different markets but all expected to deliver real rewards for shareholders next year and beyond. Assura The NHS is in a mess. More than six million people are waiting for treatment and half of them have been on waiting lists for four months or more. Cancer targets are continually missed, A&E waiting times are a national disgrace, and GPs are stretched to breaking point. To cap it all, the nation is becoming less healthy, with obesity levels rising, heart disease increasing, and life expectancy falling in the poorest parts of Britain. Change is needed – and Assura is helping to provide this. It designs, builds and manages healthcare facilities, from GP surgeries and NHS training centres to mental health units and private hospitals. Today, Assura has about 620 properties, two-thirds of which are GP surgeries, while private hospitals account for a quarter of the group. Many households regard private hospitals as greedy, price-gouging businesses. However, these are not just used by wealthy clients but also the NHS, helping to shorten waiting times and offering specialist services that the state simply cannot afford. Nuffield Health for example, Assura's largest customer on the private side, is a charity focused on community wellbeing. Assura designs, builds and manages healthcare facilities, from GP surgeries and NHS training centres to mental health units and private hospitals (picture posed by models) On the GP front, Assura surgeries are often modern and purpose-built, designed in consultation with doctors to create an environment that works for patients and medics alike. Chief executive Jonathan Murphy joined the group as finance director in 2013, rising to the top job four years later. Well regarded, Murphy is determined to build a business that improves Britain's health and delivers rewards for investors. Earnings and dividends have risen steadily over the past decade and last summer, Murphy spent £500 million on a portfolio of 14 hospitals, which are expected to drive growth for 2025 and beyond. Even after splashing out on the new assets, Assura is still forecast to increase dividends by 3 per cent to 3.3 p in the year to March 2025, putting the shares on a generous 8.5 per cent yield. Midas verdict: Property firms have been savaged recently and Assura is no exception, with its shares almost halving in value since 2022. This seems excessive. Health Secretary Wes Streeting is determined to make his mark and Assura is well positioned to benefit, as the government strives to ease pressure on the Health Service by encouraging greater use of GP surgeries and private hospitals. At 38p, the shares offer long-term growth and highly attractive dividends. Buy. Traded on: Main market Ticker: AGR Contact: assuraplc.com Telecom Plus American statesman Benjamin Franklin is credited with coining the phrase that nothing in this world is certain except death and taxes. But its first recorded mention was actually in a work by British playwright Christopher Bullock. For most of us today, though, another certainty is monthly bills. Never welcome, their number seems to increase on a regular basis – gas, electricity, broadband, mobile, insurance, plus numerous subscriptions to everything from TV to toilet paper. Telecom Plus aims to simplify customers' lives, with one bill covering energy, internet use, mobile phones and home insurance. Starting out from a pub in Henley-on-Thames in 1996, the company has more than a million customers and is valued on the stock market at almost £1.4 billion. Operating under the brand name Utility Warehouse, the group is focused on delivering top-tier service, ease of use and consistently competitive pricing. Accolades and awards suggest that the business is true to its word, as it has just been ranked number one for energy by Citizens Advice. Not only does Telecom Plus differ from peers in the range of services on offer, but it also acquires customers primarily by recommendations from existing users. Ordinary people – teachers, nurses, firefighters, police – tell friends, family or neighbours about Utility Warehouse and are rewarded for every person that they convert. Payment comes as a percentage of the new customer's bill – generally about 2.5 per cent – and for serial recommenders, known as agents, the rewards can be substantial, stretching to hundreds of pounds a year. The system is highly unusual but it works, with customer numbers – and profits – growing by more than 10 per cent a year for the past three years and set to continue. Chief executive Stuart Burnett is keen to double customer numbers to two million over the next five to seven years and add more services to his roster, with motor and pet insurance high on his list. Customers receive a loyalty card too, which takes money off their bill when they buy goods at chains such as Sainsbury's and Boots. Savings can run into hundreds of pounds for committed customers. The more customers join the group, the more profitable it becomes and the more dividends can be paid to shareholders. Shares guru Joanne Hart recommends that you buy and hold shares in Telecom Plus Brokers forecast a dividend of 94p for the year to March 2025, rising to £1.07 the following year and £1.18 in 2027. With the shares at £17.28, that puts Telecom Plus on a yield of almost 5.5 per cent. Midas verdict: Telecom Plus shares peaked at more than £25 two years ago, when energy prices were soaring and inflation was rampant. They have fallen 30 per cent since then to £17.28, with investors worried that new customers will be harder to find in today's environment. Evidence to date would suggest otherwise and the shares should bounce back in 2025 and beyond. Buy and hold. Traded on: Main market Ticker: TEP Contact: telecomplus.co.uk Distribution Finance Capital Staycations came into their own after the Covid pandemic and many holidaymakers decided they preferred them. More than 500,000 caravans trundle round the UK each year, demand for campervans and motorhomes has been soaring, and sales of new vehicles top 25,000 annually. Manchester-based Distribution Finance (DF) Capital oils the wheels of this market and its prospects are bright. The company provides finance to hundreds of dealers nationwide, via loans that are repaid as soon as vehicles are sold. Loans are subsidised by manufacturers so DF works with these firms as well, ensuring processes run smoothly from start to finish. Founded in 2016 by a trio of financial specialists who cut their teeth at US giant GE Capital, DF aims to stand out from larger competitors through a combination of top-tier technology and old-fashioned, personal service. Read More Where you should invest your money to set yourself up for a prosperous 2025, by JEFF PRESTRIDGE Rivals tend to be large banks, saddled with legacy IT. DF has built its own systems, which are easy to use by makers and dealers. Motorhomes and caravans account for about a quarter of DF's business. However, the group operates in several other areas too, from boats and motorbikes to pre-fabricated holiday homes and lodges for retirement communities. The latter are increasingly popular for older couples looking to downsize, release some funds and have fun in their senior years. Trading is brisk across the group. Working with almost 100 manufacturers and about 1,200 dealers, DF is growing fast. Chief executive Carl D'Ammassa revealed earlier this month that results for 2024 would be significantly ahead of expectations with profits of more than £18.5 million, a fourfold increase over 2023. There are high hopes for 2025 as well, with D'Ammassa planning to offer loans not just to dealers but to their customers too. The motor finance market has become enmeshed in scandal, with dealers and lenders accused of hiding commissions and overcharging customers. DF Capital will focus on specialist vehicles rather than cars, but should benefit as lenders across the industry struggle with past problems. D'Ammassa intends to start small as well, so he can be choosy in his choice of customers and keep credit quality high. DF runs a fully licensed savings bank too, financing its lending activity by offering consumers attractive rates, simple online processes and, again, friendly personal service for those who need it. Midas verdicT: Distribution Finance shares topped £1.30 in 2019. Today, they are 36p, hit by concerns about Covid, high interest rates and the collapse of a troublesome manufacturer, Royale Life, in 2023. That issue has been resolved, important lessons have been learned and DF shares have come off earlier lows. However, they are still too cheap at 36p and should deliver strong growth in 2025 and beyond. Buy. Traded on: Aim Ticker: DFCH Contact: dfcapital-investors.com IIG Gambling in China dates back at least 3,000 years, starting with an ancient precursor to chess, known as liubo. Today, however, most forms of gambling are illegal in the People's Republic, with two notable exceptions: the Welfare Lottery and the Sports Lottery, both of which are state-owned. Here too, there are restrictions, with lottery tickets historically available at just 200,000 designated shops, scattered across a country almost 40 times larger than Britain. Chinese New Year lottery tickets. About 100 million Chinese play the lottery today, out of a population of 1.4 billion Ten years ago, Englishman Daniel Levine and his Chinese colleague Frank Li Tong decided this presented a once-in-a-lifetime opportunity to drag Chinese lottery systems into the modern era and allow consumers to buy tickets online. The duo founded Hui10 to bring their idea to fruition and in 2023, UK-listed Intuitive Investments Group (IIG) acquired the business via a $365 million all-share deal. Aim-listed IIG boasts an impressive team. Chief executive Robert Naylor and chief investment officer Giles Willits have made serious money for shareholders in recent roles and hope to do the same again. Chairman Sir Nigel Rudd has a 40-year history of backing winners and believes Hui10 will turn IIG into a FTSE 100 business, so much so that he has persuaded top financiers to invest in the company. At the coalface, Levine and Tong have spent the past decade working with Chinese government bodies and local businesses. Now they are on the cusp of delivery. Systems have been approved and steps are under way to make China's lottery digital, including trial runs in certain parts of the country and promotional schemes with giants such as AliBaba, the Chinese equivalent of Amazon. A full roll-out is expected next year and the stakes are high. About 100 million Chinese play the lottery today, out of a population of 1.4 billion. If China were to follow the UK and America, those numbers could rise to at least 300 million over the next five years, sending IIG revenues from virtually nothing today to more than £1.5 billion, with profits running into hundreds of millions of pounds. Midas verdict: IIG shares are £1.10 today. If all goes according to plan, the stock could soar. Like any early-stage business, IIG is not without risk. But the board is top drawer, backers are savvy and Hui10 is determined to succeed. An appealing punt for the adventurous investor. Traded on: Aim Ticker: IIG Contact: iigplc.com Share or comment on this article: These are the four up-and-coming British companies I recommend investing in for real rewards next year and beyond, by shares guru JOANNE HART e-mail Add comment Some links in this article may be affiliate links. If you click on them we may earn a small commission. That helps us fund This Is Money, and keep it free to use. We do not write articles to promote products. We do not allow any commercial relationship to affect our editorial independence.
Seattle Seahawks receiver is DK Metcalf is just fine when he doesn't have the the ball because it means he gets to showcase his blocking skills. “I just look at it as a sign of respect that I’ve gained from other defensive coordinators and just continue to do my job with it as blocking or being a decoy,” the two-time Pro Bowler said. While opposing defenses have keyed in on Metcalf, other aspects of Seattle's offense have surfaced during its four-game winning streak. The run has the Seahawks (8-5) sitting atop the NFC West heading into Sunday night's game against the visiting Green Bay Packers (9-4). Geno Smith's new top target is second-year receiver Jaxon Smith-Njigba, who needs 89 receiving yards for his first career 1,000-yard season. Smith-Njigba has 75 catches for 911 yards and five touchdowns, while Metcalf, often dealing with double coverage, has 54 catches for 812 yards and two scores. Metcalf says he feels the pride of a “proud parent or a big brother” when it comes to Smith-Njigba's success. Seattle's offense also got a boost from the ground game in a 30-18 victory over the Arizona Cardinals last weekend . Zach Charbonnet, filling in for the injured Kenneth Walker III, ran for a career-best 134 yards and two touchdowns. The Seahawks face another hot team in the Packers (9-4), who have won seven of nine. Green Bay's two losses over that stretch have come against NFC-best Detroit (12-1), including a 34-31 victory by the Lions on Dec. 5, which means the NFC North title is likely out of reach for the Packers. The Packers are well-positioned for a playoff berth, but that almost certainly won't come this weekend. They would need a win, a loss or tie by the Atlanta Falcons and a tie between the Los Angeles Rams and San Francisco 49ers. Metcalf, who learned to block from his father, former Chicago Bears offensive lineman Terrence Metcalf, says he tries to take blocking seriously to set himself apart from other receivers. His priorities are simple when he's getting double-teamed and the ball goes elsewhere. “Trying to block my (butt) off and trying to get pancakes on defensive backs,” he said. Love heats up When the Packers surged their way into the playoffs last season, quarterback Jordan Love was a major reason why. He had 18 touchdown passes and one interception during Green Bay's final eight games. During the last four games of this season, Love ranks third in the NFL with a 118.9 passer rating with six touchdowns, one interception and a league-best 10.3 yards per attempt. “I always feel like I can put the ball where I want to — and that’s part of it, too, having that confidence to be able to throw those passes,” Love said. “There’s always like I said a handful of plays that might not come off or be in the exact spot that you wanted it to or the throw might be a little bit off. So, that’s where you’ve just got to try to be at your best every play, be consistent and accurate as possible.” Passing fancy Green Bay’s pass defense has been picked apart the last two weeks. First, it was torched by Tua Tagovailoa and the Dolphins in a Packers win. Next, it allowed Jared Goff to complete his final 13 passes as the Lions rallied to victory. It won’t get any easier this week. Smith is second in the NFL in attempts, completions and passing yards and is fifth in completion percentage. “It’s been a remarkable turnaround for him in terms of just where he started,” Packers coach Matt LaFleur said. “It’s not always where you start, but where you finish. And it tells me a lot about the person in terms of his resiliency and ability to fight through some adversity. He’s a dangerous quarterback.” The potential return of former All-Pro cornerback Jaire Alexander (knee) could help the Packers. Fashion forward Will the Packers break out their head-to-toe white uniforms? The last time Green Bay wore the winter white look was in a 24-22 win over Houston in October. The Packers asked fans to weigh in on social media . As for the Seahawks, they'll be sporting their “Action Green” uniforms. Metcalf is a fan. “I would say this about the Action Green, I love them personally in my opinion, but the big guys hate them. I don’t know why, don’t ask me," he said. “Hopefully, the Packers wear all white, so it’ll be a fun-looking game.” AP NFL: https://apnews.com/hub/nfl
In star-studded 'Conclave,' newcomer Carlos Diehz steals the spotlightIntech Investment Management LLC acquired a new position in McGrath RentCorp ( NASDAQ:MGRC – Free Report ) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 7,566 shares of the financial services provider’s stock, valued at approximately $797,000. Several other institutional investors have also modified their holdings of the company. Swedbank AB grew its position in McGrath RentCorp by 66.7% in the second quarter. Swedbank AB now owns 200,000 shares of the financial services provider’s stock worth $21,310,000 after buying an additional 80,000 shares during the last quarter. Vaughan Nelson Investment Management L.P. raised its position in shares of McGrath RentCorp by 26.0% during the second quarter. Vaughan Nelson Investment Management L.P. now owns 486,190 shares of the financial services provider’s stock worth $51,803,000 after purchasing an additional 100,210 shares during the period. Quest Partners LLC purchased a new stake in shares of McGrath RentCorp during the second quarter valued at $1,064,000. CANADA LIFE ASSURANCE Co boosted its position in shares of McGrath RentCorp by 138.9% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 9,266 shares of the financial services provider’s stock valued at $1,144,000 after purchasing an additional 5,388 shares during the period. Finally, Alpine Associates Management Inc. increased its stake in McGrath RentCorp by 9.8% in the 2nd quarter. Alpine Associates Management Inc. now owns 710,853 shares of the financial services provider’s stock worth $75,741,000 after purchasing an additional 63,366 shares in the last quarter. Institutional investors and hedge funds own 92.05% of the company’s stock. McGrath RentCorp Stock Up 0.5 % Shares of McGrath RentCorp stock opened at $121.85 on Friday. McGrath RentCorp has a 12 month low of $95.50 and a 12 month high of $130.86. The stock has a market cap of $2.99 billion, a PE ratio of 13.32, a price-to-earnings-growth ratio of 1.70 and a beta of 0.74. The business has a fifty day simple moving average of $113.07 and a 200-day simple moving average of $108.80. McGrath RentCorp Announces Dividend The business also recently disclosed a quarterly dividend, which was paid on Thursday, October 31st. Shareholders of record on Thursday, October 17th were paid a $0.475 dividend. The ex-dividend date of this dividend was Thursday, October 17th. This represents a $1.90 annualized dividend and a yield of 1.56%. McGrath RentCorp’s dividend payout ratio is presently 20.77%. Analysts Set New Price Targets A number of analysts have commented on MGRC shares. Oppenheimer upped their price objective on shares of McGrath RentCorp from $124.00 to $139.00 and gave the company an “outperform” rating in a research note on Friday, November 22nd. StockNews.com upgraded shares of McGrath RentCorp from a “sell” rating to a “hold” rating in a research report on Tuesday, October 22nd. Read Our Latest Research Report on MGRC Insider Buying and Selling at McGrath RentCorp In other McGrath RentCorp news, VP David M. Whitney sold 5,176 shares of the business’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $117.00, for a total value of $605,592.00. Following the transaction, the vice president now owns 205 shares in the company, valued at $23,985. The trade was a 96.19 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website . Also, CEO Joseph F. Hanna sold 15,840 shares of the firm’s stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $119.88, for a total value of $1,898,899.20. Following the sale, the chief executive officer now directly owns 155,409 shares of the company’s stock, valued at $18,630,430.92. This trade represents a 9.25 % decrease in their ownership of the stock. The disclosure for this sale can be found here . In the last quarter, insiders have sold 47,016 shares of company stock worth $5,493,411. 1.60% of the stock is currently owned by company insiders. McGrath RentCorp Profile ( Free Report ) McGrath RentCorp operates as a business to business rental company in the United States and internationally. It rents and sells relocatable modular buildings, portable storage containers, and electronic test equipment. The company operates through four segments: Mobile Modular, Portable Storage, TRS-RenTelco, and Enviroplex. Recommended Stories Five stocks we like better than McGrath RentCorp Bank Stocks – Best Bank Stocks to Invest In The Latest 13F Filings Are In: See Where Big Money Is Flowing Upcoming IPO Stock Lockup Period, Explained 3 Penny Stocks Ready to Break Out in 2025 Breakout Stocks: What They Are and How to Identify Them FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential Want to see what other hedge funds are holding MGRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McGrath RentCorp ( NASDAQ:MGRC – Free Report ). Receive News & Ratings for McGrath RentCorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McGrath RentCorp and related companies with MarketBeat.com's FREE daily email newsletter .